Abbott Laboratories (ABT)

Short-Term Debt

$3.01B

Quarterly · Period ending: · USD

ABT logo

ABT Short-Term Debt

Latest reported$3.01B
ABT Quarterly Short-Term Debt ($122.90M → $3.01B)
High-resolution chart · PNG

ABT short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
3,242,091,000
5,966,820,000
479,454,000
547,022,000
355,594,000
909,117,000
896,271,000
872,791,000
982,861,000
1,286,394,000
1,759,076,000
1,419,970,000
1,575,454,000
1,290,488,000
1,781,352,000
1,637,794,000
1,462,764,000
1,201,912,000
1,383,727,000
1,451,543,000
1,670,537,000
675,337,000
1,049,863,000
937,193,000
829,594,000
883,548,000
772,503,000
764,265,000
745,798,000
675,432,000
843,594,000
971,400,000
1,003,100,000
872,600,000
916,300,000
857,400,000
531,500,000
672,500,000
544,300,000
533,000,000
584,800,000
582,600,000
663,800,000
935,000,000
745,200,000
536,300,000
300,500,000
493,300,000
606,400,000
591,700,000
122,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.